Filing Details
- Accession Number:
- 0001104659-24-081887
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-23 16:05:09
- Reporting Period:
- 2024-07-19
- Accepted Time:
- 2024-07-23 16:05:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1400118 | Sagimet Biosciences Inc. | SGMT | Pharmaceutical Preparations (2834) | 205991472 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1858176 | George Kemble | Sagimet Biosciences Inc. 155 Bovet Rd., Suite 303 San Mateo CA 94402 | Executive Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Series A Common Stock | Disposition | 2024-07-19 | 14,062 | $3.10 | 142,318 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.
Billionaire Hedge Funds
